Medical decisions are based on the analysis of diagnostic data with the aim of providing the best possible treatment for each individual patient. As medical data becomes increasingly abundant and digital, it provides an ideal application field for AI, which has the potential to integrate these vast resources and uncover hidden patterns to guide, optimize and personalize therapeutic options.
In this year´s international “RegMed Forum: Will AI Transform Regenerative Medicine?” on December 1 in Berlin, Germany, stakeholders from industry, clinics and academia will provide an overview of current use of AI in medicine, the challenges that come with it, and the transformational potential for regenerative therapies.
We are proud to present Stefano Bini from the UCSF Medical Center, USA, and others (see agenda here) and to have stimulating discussions with you.
For more information and registration please visit our website: RegMed Forum: Will AI Transform Regenerative Medicine?
Participation is free of charge.
Who will be attending?
We are expecting companies, clinicians and academic researchers from the German capital region and beyond looking for co-development or joint research opportunities, as well as start-ups with new ideas and innovative approaches.
About the event
The Berlin Institute of Health at Charité (BIH), the BIH Center for Regenerative Therapies (BCRT), Charité – Universitätsmedizin Berlin and the Cluster Health Capital Berlin-Brandenburg are jointly organizing the international RegMed Forum since 2014.
This event series provides the opportunity to hear and discuss science in the field of regenerative medicine - from basic research to clinical implementation and industrialization. In addition to a comprehensive scientific program there will be opportunities to network and discuss with industry and research groups in the regenerative medicine field.
About BIH Center for Regenerative Therapies (BCRT)
The research landscape of Berlin-Brandenburg has developed into one of the most important international clusters for regenerative medicine. A major contribution to this development has been the BCRT - an interdisciplinary clinical translational center operated by the Berlin Institute of Health BIH.
The primary focus of the BCRT is the development of novel methods to promote endogenous regeneration to address acute and chronic diseases of the immune, musculoskeletal and cardiovascular systems. This includes using cells, biomaterials and biological factors or a combination thereof to provide long-term and possibly curative treatments. With respect to the development and implementation of innovative therapies and products from the BCRT, the first potential success story for a novel regenerative product is starting to emerge. Virus-specific T-cell products for long-term protection against serious infections are being evaluated in onsite clinical studies for treatment of patients with a weakened immune system. Following the concept of refined translation, i.e. iterative incorporation of (pre-) clinical research findings into product development, and the use of biomarkers, the BCRT is actively pushing further treatment concepts towards clinical evaluation. This also includes new cell-based therapies for heart disease and muscle injuries.
About the Cluster Health Capital
The German capital region is one of the world's leading locations for the healthcare industry, healthcare, and the life sciences. Leading global companies, renowned scientists, first-class hospitals, innovative start-ups, and specialists from all over the world work together in Berlin-Brandenburg each day to deliver the very best goods and services for the regional and global healthcare markets.
The cluster management team at Berlin Partner for Business and Technology and Brandenburg Economic Development Corporation (WFBB) drives networking and the technology transfer in the region and supports international companies interested in relocating to the German capital region.
Compliance with Corona rules
The event will take place in compliance with the currently valid Corona rules. Please note that the RegMed Forum 2022 will be held onsite if regulations allow. As we can only provide limited space for onsite participation, we kindly ask you to only register if you are able to join in person. The maximum participant capacity might have to be adjusted in case Corona rules change.